Type your tag names separated by a space and hit enter

Practice parameter on the use of psychotropic medication in children and adolescents.

Abstract

The purpose of this practice parameter is to promote the appropriate and safe use of psychotropic medications in children and adolescents with psychiatric disorders by emphasizing the best practice principles that underlie medication prescribing. The evidence base supporting the use of psychotropic medication for children and adolescents with psychiatric disorders has increased for the past 15 to 20 years, as has their use. It is hoped that clinicians who implement the principles outlined in this parameter will be more likely to use medications with the potential for pharmacological benefit in children safely and to reduce the use of ineffective and inappropriate medications or medication combinations. The best practice principles covered in this parameter include completing a psychiatric and medical evaluation, developing a treatment and monitoring plan, educating the patient and family regarding the child's disorder and the treatment and monitoring plan, completing and documenting assent of the child and consent of the parent, conducting an adequate medication treatment trial, managing the patient who does not respond as expected, establishing procedures to implement before using medication combinations, and following principles for the discontinuation of medication.

Links

  • Publisher Full Text
  • Authors

    Source

    MeSH

    Adolescent
    Child
    Combined Modality Therapy
    Dose-Response Relationship, Drug
    Drug Therapy, Combination
    Evidence-Based Medicine
    Follow-Up Studies
    Humans
    Mental Disorders
    Parents
    Patient Care Planning
    Patient Education as Topic
    Psychotherapy
    Psychotropic Drugs

    Pub Type(s)

    Consensus Development Conference
    Journal Article
    Practice Guideline

    Language

    eng

    PubMed ID

    19692857

    Citation

    American Academy of Child and Adolescent Psychiatry. "Practice Parameter On the Use of Psychotropic Medication in Children and Adolescents." Journal of the American Academy of Child and Adolescent Psychiatry, vol. 48, no. 9, 2009, pp. 961-73.
    American Academy of Child and Adolescent Psychiatry. Practice parameter on the use of psychotropic medication in children and adolescents. J Am Acad Child Adolesc Psychiatry. 2009;48(9):961-73.
    American Academy of Child and Adolescent Psychiatry. (2009). Practice parameter on the use of psychotropic medication in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 48(9), pp. 961-73. doi:10.1097/CHI.0b013e3181ae0a08.
    American Academy of Child and Adolescent Psychiatry. Practice Parameter On the Use of Psychotropic Medication in Children and Adolescents. J Am Acad Child Adolesc Psychiatry. 2009;48(9):961-73. PubMed PMID: 19692857.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Practice parameter on the use of psychotropic medication in children and adolescents. A1 - ,, PY - 2009/8/21/entrez PY - 2009/8/21/pubmed PY - 2009/12/16/medline SP - 961 EP - 73 JF - Journal of the American Academy of Child and Adolescent Psychiatry JO - J Am Acad Child Adolesc Psychiatry VL - 48 IS - 9 N2 - The purpose of this practice parameter is to promote the appropriate and safe use of psychotropic medications in children and adolescents with psychiatric disorders by emphasizing the best practice principles that underlie medication prescribing. The evidence base supporting the use of psychotropic medication for children and adolescents with psychiatric disorders has increased for the past 15 to 20 years, as has their use. It is hoped that clinicians who implement the principles outlined in this parameter will be more likely to use medications with the potential for pharmacological benefit in children safely and to reduce the use of ineffective and inappropriate medications or medication combinations. The best practice principles covered in this parameter include completing a psychiatric and medical evaluation, developing a treatment and monitoring plan, educating the patient and family regarding the child's disorder and the treatment and monitoring plan, completing and documenting assent of the child and consent of the parent, conducting an adequate medication treatment trial, managing the patient who does not respond as expected, establishing procedures to implement before using medication combinations, and following principles for the discontinuation of medication. SN - 1527-5418 UR - https://www.unboundmedicine.com/medline/citation/19692857/full_citation L2 - https://linkinghub.elsevier.com/retrieve/pii/S0890-8567(09)60156-8 DB - PRIME DP - Unbound Medicine ER -